Clinical Trials
3 trialsNCT06551116 2026-04-07
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
Abramson Cancer Center at Penn Medicine
Recruiting
NCT06305702 2024-03-12
Real-world Study of Inetetamab in HER2-positive Metastatic Breast Cancer
Liaoning Cancer Hospital & Institute
Completed
NCT05188495 2022-01-12
HELP
Peking University Cancer Hospital & Institute
Unknown